ABBVIE INC (ABBV) Stock Analyst Ratings
NYSE:ABBV - New York Stock Exchange, Inc. - US00287Y1091 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 80% to ABBV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 217.88. This target is 18.89% above the current price.
ABBV was analyzed by 34 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ABBV.
In the previous month the buy percentage consensus was at a similar level.
ABBV was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-14 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-04-29 | Guggenheim | Maintains | Buy -> Buy |
| 2025-04-28 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-04-28 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-04-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-04-17 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-03-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-03-04 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-02-03 | Guggenheim | Maintains | Buy -> Buy |
| 2025-02-03 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-02-03 | UBS | Maintains | Neutral -> Neutral |
| 2025-02-03 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-03 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-02-03 | Truist Securities | Maintains | Buy -> Buy |
| 2025-02-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-02-03 | Citigroup | Maintains | Buy -> Buy |
| 2025-01-28 | Citigroup | Maintains | Buy -> Buy |
| 2025-01-08 | Truist Securities | Maintains | Buy -> Buy |
| 2024-12-17 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-12-10 | B of A Securities | Reiterate | Neutral |
| 2024-11-22 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-11-15 | Wolfe Research | Initiate | Outperform |
| 2024-11-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-11-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-11-12 | Citigroup | Maintains | Buy -> Buy |
| 2024-11-06 | Guggenheim | Maintains | Buy -> Buy |
| 2024-11-04 | Argus Research | Upgrade | Hold -> Buy |
| 2024-10-31 | UBS | Maintains | Neutral -> Neutral |